Benedict Financial Advisors Inc. Has $10.83 Million Holdings in Johnson & Johnson (NYSE:JNJ)
Benedict Financial Advisors Inc. Has $10.83 Million Holdings in Johnson & Johnson (NYSE:JNJ)
Benedict Financial Advisors Inc. lifted its position in Johnson & Johnson (NYSE:JNJ – Get Rating) by 2.7% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 61,001 shares of the company's stock after buying an additional 1,605 shares during the quarter. Johnson & Johnson comprises 3.2% of Benedict Financial Advisors Inc.'s investment portfolio, making the stock its 3rd largest holding. Benedict Financial Advisors Inc.'s holdings in Johnson & Johnson were worth $10,828,000 at the end of the most recent reporting period.
据本尼迪克特金融顾问公司在最近提交给美国证券交易委员会的13F文件中称，该公司在第二季度将其在强生(纽约证券交易所代码：JNJ-GET评级)的持仓上调了2.7%。该机构投资者在本季度额外购买了1,605股后，持有该公司61,001股股票。强生在本尼迪克特金融顾问公司的投资组合中占3.2%，是其第三大持股。截至最近一次报告期结束时，本尼迪克特金融顾问公司持有的强生股份价值10,828,000美元。
Several other large investors have also made changes to their positions in the company. Howard Financial Services LTD. raised its stake in shares of Johnson & Johnson by 2.1% in the first quarter. Howard Financial Services LTD. now owns 2,757 shares of the company's stock valued at $489,000 after purchasing an additional 57 shares in the last quarter. American Financial Advisors LLC raised its stake in shares of Johnson & Johnson by 2.1% in the first quarter. American Financial Advisors LLC now owns 2,715 shares of the company's stock valued at $481,000 after purchasing an additional 57 shares in the last quarter. Taylor & Morgan Wealth Management LLC grew its position in Johnson & Johnson by 1.6% in the second quarter. Taylor & Morgan Wealth Management LLC now owns 3,580 shares of the company's stock valued at $635,000 after acquiring an additional 57 shares during the period. Kwmg LLC grew its position in Johnson & Johnson by 2.6% in the first quarter. Kwmg LLC now owns 2,354 shares of the company's stock valued at $417,000 after acquiring an additional 59 shares during the period. Finally, Circle Wealth Management LLC grew its position in Johnson & Johnson by 0.5% in the first quarter. Circle Wealth Management LLC now owns 11,326 shares of the company's stock valued at $2,007,000 after acquiring an additional 59 shares during the period. Institutional investors own 68.59% of the company's stock.
其他几家大型投资者也对他们在该公司的头寸进行了调整。霍华德金融服务有限公司第一季增持强生股份2.1%.霍华德金融服务有限公司在上个季度又购买了57股后，现在拥有2,757股该公司股票，价值48.9万美元。美国金融顾问公司第一季度增持强生股份2.1%.American Financial Advisors LLC现在持有该公司2,715股股票，价值481,000美元，上个季度又购买了57股。泰勒·摩根财富管理有限责任公司第二季度增持了强生的股份，增幅为1.6%。Taylor&Morgan Wealth Management LLC现在拥有3580股该公司股票，价值63.5万美元，在此期间又购买了57股。第一季度，Kumg LLC在强生的持仓增加了2.6%。在此期间收购了另外59股后，Kumg LLC现在拥有2354股该公司的股票，价值41.7万美元。最后，圈子财富管理有限责任公司在第一季度对强生的持仓增长了0.5%。Circle Wealth Management LLC现在拥有11,326股该公司的股票，价值2,007,000美元，在此期间又购买了59股。机构投资者持有该公司68.59%的股份。
Analyst Ratings Changes
分析师评级发生变化
A number of brokerages have weighed in on JNJ. Sanford C. Bernstein lowered their price target on Johnson & Johnson from $194.00 to $190.00 in a research report on Wednesday, October 19th. UBS Group lowered their price target on Johnson & Johnson from $185.00 to $180.00 in a research report on Thursday, July 21st. StockNews.com began coverage on Johnson & Johnson in a research report on Wednesday, October 12th. They issued a "strong-buy" rating on the stock. Atlantic Securities decreased their target price on Johnson & Johnson from $165.00 to $160.00 and set a "neutral" rating on the stock in a report on Wednesday, October 19th. Finally, Raymond James decreased their target price on Johnson & Johnson from $192.00 to $185.00 and set an "outperform" rating on the stock in a report on Wednesday, October 19th. Six analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Johnson & Johnson has an average rating of "Moderate Buy" and an average price target of $184.25.
许多券商都加入了对JNJ的看法。桑福德·伯恩斯坦在10月19日星期三的一份研究报告中将强生的目标价从194.00美元下调至190.00美元。7月21日，瑞银集团在一份研究报告中将强生的目标价从185.00美元下调至180.00美元。10月12日，星期三，斯托克新闻网开始在一份研究报告中对强生进行报道。他们对该股的评级为“强力买入”。大西洋证券在10月19日(周三)的一份报告中将强生的目标价从165.00美元下调至160.00美元，并将该股的评级定为“中性”。最后，雷蒙德·詹姆斯在10月19日(周三)的一份报告中将强生的目标价从192.00美元下调至185.00美元，并对该股设定了“跑赢大盘”的评级。六位分析师对该股的评级为持有，五位分析师发布了买入评级，一位分析师对该股给予了强烈的买入评级。根据MarketBeat.com的数据，强生的平均评级为“中等买入”，平均目标价为184.25美元。
Johnson & Johnson Price Performance
强生性价比
Johnson & Johnson (NYSE:JNJ – Get Rating) last released its earnings results on Tuesday, October 18th. The company reported $2.55 earnings per share for the quarter, beating the consensus estimate of $2.49 by $0.06. Johnson & Johnson had a return on equity of 35.32% and a net margin of 19.95%. The firm had revenue of $23.79 billion for the quarter, compared to analyst estimates of $23.44 billion. During the same quarter in the prior year, the firm posted $2.60 earnings per share. The company's quarterly revenue was up 1.9% on a year-over-year basis. As a group, research analysts anticipate that Johnson & Johnson will post 10.05 earnings per share for the current year.
强生(纽约证券交易所代码：JNJ-GET Rating)最近一次发布收益报告是在10月18日(星期二)。该公司公布本季度每股收益为2.55美元，比普遍预期的2.49美元高出0.06美元。强生的股本回报率为35.32%，净利润率为19.95%。该公司本季度营收为237.9亿美元，而分析师预期为234.4亿美元。去年同期，该公司公布的每股收益为2.60美元。该公司季度营收同比增长1.9%。作为一个整体，研究分析师预计强生本年度每股收益将为10.05%。
Johnson & Johnson Dividend Announcement
强生分红公告
The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 6th. Shareholders of record on Tuesday, November 22nd will be paid a $1.13 dividend. This represents a $4.52 annualized dividend and a yield of 2.69%. The ex-dividend date is Monday, November 21st. Johnson & Johnson's payout ratio is 62.95%.
该业务最近还宣布了季度股息，将于12月6日(星期二)支付。11月22日(星期二)登记在册的股东将获得1.13美元的股息。这意味着年化股息为4.52美元，收益率为2.69%。除息日期为11月21日(星期一)。强生的派息率为62.95%.
Johnson & Johnson announced that its board has approved a share buyback program on Wednesday, September 14th that allows the company to buyback $5.00 billion in outstanding shares. This buyback authorization allows the company to reacquire up to 1.2% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's board of directors believes its stock is undervalued.
强生宣布，董事会已于9月14日(星期三)批准了一项股票回购计划，允许公司回购50亿美元的流通股。这项回购授权允许该公司通过公开市场购买重新获得高达1.2%的股份。股票回购计划通常是公司董事会认为其股票被低估的迹象。
Insider Buying and Selling at Johnson & Johnson
强生的内幕买卖
In other Johnson & Johnson news, VP Peter Fasolo sold 22,864 shares of the stock in a transaction dated Wednesday, October 19th. The stock was sold at an average price of $164.50, for a total value of $3,761,128.00. Following the transaction, the vice president now owns 114,676 shares of the company's stock, valued at $18,864,202. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.35% of the company's stock.
在强生的另一则消息中，副总裁彼得·法索洛在10月19日星期三的交易中出售了22,864股该股。这只股票的平均售价为164.50美元，总价值为3761,128.00美元。交易完成后，副总经理总裁现在持有该公司114,676股股票，价值18,864,202美元。这笔交易是在提交给美国证券交易委员会的一份法律文件中披露的，该文件可在这个环节。内部人士持有该公司0.35%的股份。
Johnson & Johnson Profile
强生简介
(Get Rating)
(获取评级)
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR.
强生及其子公司在全球范围内研发、制造和销售医疗保健领域的各种产品。该公司的消费者健康部门提供Johnson‘s和AVEENO Baby品牌的婴儿护理产品；Listerine品牌的口腔护理产品；AVEENO，Clean&Clear，Dr.
Featured Stories
专题报道
- Get a free copy of the StockNews.com research report on Johnson & Johnson (JNJ)
- Time to Hit Up Hasbro Stock for the Holiday Season
- Should Proctor and Gamble be a Staple in Your Portfolio?
- 3 Fundamentally Sound Mid-Caps to Keep on the Watch List
- Leveraged ETFs, A Bad Investment But Great for Trading
- Should Investors Raise a Glass to Boston Beer Company?
- 免费获取斯托克新闻网关于强生(JNJ)的研究报告
- 是时候为假日季大涨孩之宝股票了
- 宝洁应该成为你投资组合中的主打产品吗？
- 3个基本面稳健的中型股将继续留在观察名单上
- 杠杆ETF是一种糟糕的投资，但对交易有利
- 投资者应该向波士顿啤酒公司举杯吗？
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.
接受《强生日报》的新闻和评级-在下面输入您的电子邮件地址，即可通过MarketBeat.com的免费每日电子邮件时事通讯接收对强生及相关公司的最新新闻和分析师评级的每日摘要。
译文内容由第三方软件翻译。